tm logo

Monitor this mark

View On USPTO

ALQELA
Live/Pending
SECOND EXTENSION - GRANTED

granted

on 26 Apr 2024

Last Applicant/ Owned by

TEVA PHARMACEUTICALS USA, Inc.

400 Interpace Parkway

Parsippany

NJ

07054

Serial Number

97386810 filed on 28th Apr 2022

Registration Number

N/A

Correspondent Address

Laurence Rickles

Laurence Rickles TEVA PHARMACEUTICALS USA, INC.

Parsippany, NJ 07054

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

ALQELA

Pharmaceutical preparations to treat the vasomotor symptoms associated with menopause, vulvar and vaginal atrophy and for the prevention of osteoporosis

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations to treat the vasomotor symptoms associated with menopause, vulvar and vaginal atrophy and for the prevention of osteoporosis

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 97386810

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
27th Apr 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
26th Apr 2024SOU EXTENSION 2 FILED
26th Apr 2024SOU EXTENSION 2 GRANTED
26th Apr 2024SOU TEAS EXTENSION RECEIVED
11th Nov 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09th Nov 2023SOU EXTENSION 1 GRANTED
09th Nov 2023SOU EXTENSION 1 FILED
09th Nov 2023SOU TEAS EXTENSION RECEIVED
16th May 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
21st Mar 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED